381 related articles for article (PubMed ID: 26030588)
21. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia.
Schuetz P; Litke A; Albrich WC; Mueller B
Curr Opin Infect Dis; 2013 Apr; 26(2):159-67. PubMed ID: 23434895
[TBL] [Abstract][Full Text] [Related]
22. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
[TBL] [Abstract][Full Text] [Related]
23. Multidimensional Prognostic Index and pro-adrenomedullin plasma levels as mortality risk predictors in older patients hospitalized with community-acquired pneumonia: a prospective study.
Pilotto A; Dini S; Veronese N; Daragjati J; Miolo M; Mion MM; Fontana A; Lo Storto M; Zaninotto M; Bragato G; Cella A; Carraro P; Addante F; Copetti M; Plebani M
Panminerva Med; 2018 Sep; 60(3):80-85. PubMed ID: 29546738
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia.
Esposito S; Di Gangi M; Cardinale F; Baraldi E; Corsini I; Da Dalt L; Tovo PA; Correra A; Villani A; Sacco O; Tenero L; Dones P; Gambino M; Zampiero A; Principi N;
PLoS One; 2016; 11(11):e0163262. PubMed ID: 27846213
[TBL] [Abstract][Full Text] [Related]
25. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.
Haaf P; Twerenbold R; Reichlin T; Faoro J; Reiter M; Meune C; Steuer S; Bassetti S; Ziller R; Balmelli C; Campodarve I; Zellweger C; Kilchenmann A; Irfan A; Papassotiriou J; Drexler B; Mueller C
Int J Cardiol; 2013 Sep; 168(2):1048-55. PubMed ID: 23199555
[TBL] [Abstract][Full Text] [Related]
26. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
[TBL] [Abstract][Full Text] [Related]
27. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
[TBL] [Abstract][Full Text] [Related]
28. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
Zhuang Q; Zeng Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038
[TBL] [Abstract][Full Text] [Related]
29. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
[TBL] [Abstract][Full Text] [Related]
30. Adrenomedullin optimises mortality prediction in COPD patients.
Brusse-Keizer M; Zuur-Telgen M; van der Palen J; VanderValk P; Kerstjens H; Boersma W; Blasi F; Kostikas K; Milenkovic B; Tamm M; Stolz D
Respir Med; 2015 Jun; 109(6):734-42. PubMed ID: 25937049
[TBL] [Abstract][Full Text] [Related]
31. Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.
Seifert-Held T; Pekar T; Gattringer T; Simmet NE; Scharnagl H; Bocksrucker C; Lampl C; Storch MK; Stojakovic T; Fazekas F
PLoS One; 2013; 8(7):e68768. PubMed ID: 23894342
[TBL] [Abstract][Full Text] [Related]
32. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
Funke-Kaiser A; Mann K; Colquhoun D; Zeller T; Hunt D; Simes J; Sullivan D; Sydow K; West M; White H; Blankenberg S; Tonkin AM;
Int J Cardiol; 2014 Mar; 172(2):411-8. PubMed ID: 24508492
[TBL] [Abstract][Full Text] [Related]
33. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
Heining L; Giesa C; Ewig S
Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
[TBL] [Abstract][Full Text] [Related]
35. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia.
Kolditz M; Halank M; Schulte-Hubbert B; Bergmann S; Albrecht S; Höffken G
Respir Med; 2012 Sep; 106(9):1320-8. PubMed ID: 22732597
[TBL] [Abstract][Full Text] [Related]
36. Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation.
Parwani AS; von Haehling S; Kolodziejski AI; Huemer M; Wutzler A; Attanasio P; Stojakovic T; Scharnagl H; Haverkamp W; Boldt LH
Int J Cardiol; 2015 Feb; 180():129-33. PubMed ID: 25438233
[TBL] [Abstract][Full Text] [Related]
37. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.
Christ-Crain M; Morgenthaler NG; Struck J; Harbarth S; Bergmann A; Müller B
Crit Care; 2005; 9(6):R816-24. PubMed ID: 16356231
[TBL] [Abstract][Full Text] [Related]
38. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H
Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
[TBL] [Abstract][Full Text] [Related]
39. Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement.
Csordas A; Nietlispach F; Schuetz P; Huber A; Müller B; Maisano F; Taramasso M; Moarof I; Obeid S; Stähli BE; Cahenzly M; Binder RK; Liebetrau C; Möllmann H; Kim WK; Hamm C; Lüscher TF
PLoS One; 2015; 10(12):e0143761. PubMed ID: 26630012
[TBL] [Abstract][Full Text] [Related]
40. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.
Alan M; Grolimund E; Kutz A; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
J Intern Med; 2015 Aug; 278(2):174-84. PubMed ID: 25529395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
